Antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi of the potent clinical candidate VT-1161

dc.creatorHoekstra, William J.
dc.creatorHargrove, Tatiana Y,
dc.creatorWawrzak, Zdzislaw
dc.creatorBatista, Denis D. G
dc.creatorSilva, Cristiane F. da
dc.creatorNefertiti, Aline S. G.
dc.creatorRachakonda, Girish
dc.creatorSchotzinger, Robert J.
dc.creatorVillalta, Fernando
dc.creatorSoeiro, Maria Nazaré C.
dc.creatorLepesheva, Galina I.
dc.date.accessioned2018-10-18T17:50:07Z
dc.date.accessioned2023-09-05T15:59:16Z
dc.date.available2018-10-18T17:50:07Z
dc.date.available2023-09-05T15:59:16Z
dc.date.created2018-10-18T17:50:07Z
dc.date.issued2015
dc.identifierHOEKSTRA, William J. et al. Antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi of the potent clinical candidate VT-1161. Antimicrob. Agents Chemother. On line Oct. 2018.
dc.identifier0066-4804
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/29637
dc.identifier10.1128/AAC.02287-15
dc.identifier1098-6596
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8673048
dc.languageeng
dc.publisherAmerican Society for Microbiology
dc.rightsopen access
dc.titleAntiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi of the potent clinical candidate VT-1161
dc.typeArticle


Este ítem pertenece a la siguiente institución